The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Basal cell carcinoma 6
SANDOSTATIN LAR DEPOT Biliary dilatation 6
SANDOSTATIN LAR DEPOT Blood disorder 6
SANDOSTATIN LAR DEPOT Blood electrolytes abnormal 6
SANDOSTATIN LAR DEPOT Blood growth hormone decreased 6
SANDOSTATIN LAR DEPOT Carcinoid syndrome 6
SANDOSTATIN LAR DEPOT Catheter site infection 6
SANDOSTATIN LAR DEPOT Cerebral haemorrhage 6
SANDOSTATIN LAR DEPOT Coordination abnormal 6
SANDOSTATIN LAR DEPOT Diabetic neuropathy 6
SANDOSTATIN LAR DEPOT Drug administration error 6
SANDOSTATIN LAR DEPOT Extra dose administered 6
SANDOSTATIN LAR DEPOT Eye disorder 6
SANDOSTATIN LAR DEPOT Eye inflammation 6
SANDOSTATIN LAR DEPOT Facial bones fracture 6
SANDOSTATIN LAR DEPOT Fear 6
SANDOSTATIN LAR DEPOT Food allergy 6
SANDOSTATIN LAR DEPOT Full blood count abnormal 6
SANDOSTATIN LAR DEPOT Gastroenteritis 6
SANDOSTATIN LAR DEPOT Hepatic encephalopathy 6

Total Records: 2,045     Number of Pages: 103